Spearhead Capital Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,547
Closed -$703K 235
2021
Q4
$703K Buy
4,547
+44
+1% +$7.37K 0.08% 76
2021
Q3
$765K Buy
4,503
+43
+1% +$6.69K 0.1% 68
2021
Q2
$704K Buy
4,460
+394
+10% +$58.5K 0.1% 76
2021
Q1
$565K Buy
4,066
+406
+11% +$65.4K 0.08% 78
2020
Q4
$641K Buy
3,660
+36
+1% +$6.71K 0.1% 82
2020
Q3
$709K Buy
3,624
+238
+7% +$39.8K 0.14% 67
2020
Q2
$575K Buy
3,386
+274
+9% +$40.9K 0.12% 71
2020
Q1
$359K Buy
+3,112
New +$345K 0.1% 83

Other funds holding SGEN

Spearhead Capital Advisors's SGEN Position: Q1 2022 in Review

Spearhead Capital Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q1 2022, closing a stake of 4,547 shares — an estimated $703K sold.

Spearhead Capital Advisors first reported a position in SGEN in Q1 2020 and held it in 8 quarters. The position peaked at $765K in Q3 2021. 505 funds tracked by Wall St. Rank hold SGEN as of Q1 2022.

  • Spearhead Capital Advisors reported no remaining Seagen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Spearhead Capital Advisors sold 4,547 Seagen Inc. Common Stock shares in Q1 2022, an estimated $703K.
  • Spearhead Capital Advisors first reported a position in Seagen Inc. Common Stock in Q1 2020 and held it in 8 quarters.
  • Spearhead Capital Advisors's Seagen Inc. Common Stock position peaked at $765K in Q3 2021.
  • 505 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2022.

Based on Spearhead Capital Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.